Quality improvement in neurology: Parkinson disease update quality measurement set

Approximately 630, 000 people in the United States carried a diagnosis of Parkinson disease (PD) in 2010, and worldwide estimates indicate that up to 10 million individuals may be diagnosed currently. 1, 2 The national economic burden of PD was estimated to exceed 14. 4 billion in 2010. 1 PD is a heterogeneous disorder with motor and nonmotor features that are often underdiagnosed and, in turn, provided limited treatment options. The American Academy of Neurology (AAN) created a quality measurement set in 2010 to provide a framework for measuring progress on addressing these treatment gaps in care. 3 The authors thank all the Parkinson's Disease Update Quality Measurement Set Work Group members for their dedication, time, energy, contributions, and work that supported the development of this manuscript: Stewart A. Factor, DO, FAAN (Co-Chair) (American Academy of Neurology) ; Janis M. Miyasaki, MD, MEd, FRCP, FAAN (Co-Chair) (American Academy of Neurology) ; Jason Aldred, MD (American Academy of Neurology) ; Shannon Linder, DNP, FNP-BC, PMHNP (American Academy of Neurology) ; Abhimanyu Mahajan, MD, MHS (American Academy of Neurology) ; Sotirios Parashos (American Academy of Neurology) ; Marie-Hélène Saint-Hilaire, MD, FRCPC, FAAN (American Academy of Neurology) ; Aleksandar Videnovic, MD, MSc (American Academy of Neurology) ; Paul Moberg, PhD, ABPP-CN (American Academy of Clinical Neuropsychology) ; Christina Marciniak, MD (American Academy of Physical Medicine and Rehabilitation) ; Karen Freshwater, MS, PA-C (American Academy of Physician Assistants) ; Pearl Jones, MD (American Autonomic Society) ; William Ondo, MD (American Neurological Association) ; Patricia A. Totten, MA, OTR, CHT, CLT-UE (American Occupational Therapy Association) ; Deborah Kegelmeyer, DPT, MS, GCS (American Physical Therapy Association) ; Dawn Bowers, PhD, ABPP-CN (American Psychological Association) ; Linda Keilman, DNP, GNP-BC (Gerontological Advanced Practice Nurses Association) ; Anthony Geraci, MD, MSPH (National Parkinson Foundation) ; Peter Schmidt, PhD (National Parkinson Foundation) ; Anna D. Hohler, MD, FAAN (American Academy of Neurology Facilitator) ; David Wang, DO, FAAN, FAHA (American Academy of Neurology Facilitator) ; Amy Bennett, JD (American Academy of Neurology Staff) ; Gina Gjorvad (American Academy of Neurology Staff) ; Erin Hagen (American Academy of Neurology Staff) ; Becky Schierman, MPH (American Academy of Neurology Staff).